<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03722732</url>
  </required_header>
  <id_info>
    <org_study_id>F.1/IEC/MAMC/63/03/18/NO325</org_study_id>
    <nct_id>NCT03722732</nct_id>
  </id_info>
  <brief_title>Comparison of Blood Loss in Laparoscopic vs Open Pancreaticoduodenectomy in Patients With Periampullary Carcinoma</brief_title>
  <official_title>Comparison of Blood Loss in Laparoscopic vs Open Pancreaticoduodenectomy in Patients With Periampullary Carcinoma - A Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Govind Ballabh Pant Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Govind Ballabh Pant Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      the study is designed to compare the blood loss between laparoscopic vs open
      pancreaticoduodenectomy in a randomized clinical trial
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      the study will assess the difference in the amount of blood loss in Lap vs Open WPD. the
      amount of blood loss will be calculated on the basis of a formula which takes pre operative
      and post operative hematocrit, PCV and blood volume into consideration.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 11, 2018</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>intraoperative blood loss in ml, quantitative</measure>
    <time_frame>24 hours</time_frame>
    <description>blood loss will be assessed with the help of a formula which uses preoperative and post operative hematocrit, blood volume and PCV</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Periampullary Carcinoma</condition>
  <arm_group>
    <arm_group_label>Open pancreaticoduedenectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>will include all the patients who will undergo open pancreaticoduodenectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Laparoscopic pancreaticoduodenectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>will include all the patients undergoing laparoscopic pancreaticoduodenectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>pancreaticoduodenectomy</intervention_name>
    <description>pancreaticoduodenectomy either laparoscopically or open will be done</description>
    <arm_group_label>Laparoscopic pancreaticoduodenectomy</arm_group_label>
    <arm_group_label>Open pancreaticoduedenectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients of both the sex aged between &gt;18 years.

          2. Patients with a diagnosis of resectable periampullary carcinoma on imaging.

          3. Patients with ASA grade 1 or 2

        Exclusion Criteria:

          -  1) Patients found to have unresectable disease on radiological investigation. 2)
             Patients with ASA grade 3 or above
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>H H Nag, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>GBPant Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>H H Nag, MS</last_name>
    <phone>9718599260</phone>
    <email>hirdayanag@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Aditya sharma, MCH resident</last_name>
    <phone>9718599258</phone>
    <email>adi.mamc@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>G B Pant Hospital</name>
      <address>
        <city>New Delhi</city>
        <state>Delhi</state>
        <zip>110002</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>hirdaya h nag, ms</last_name>
      <phone>91 11 23234242</phone>
      <phone_ext>5220</phone_ext>
      <email>hirdayanag@gmail.com</email>
    </contact>
    <investigator>
      <last_name>hirdaya h nag, ms</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>October 2, 2018</study_first_submitted>
  <study_first_submitted_qc>October 25, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 29, 2018</study_first_posted>
  <last_update_submitted>October 25, 2018</last_update_submitted>
  <last_update_submitted_qc>October 25, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Govind Ballabh Pant Hospital</investigator_affiliation>
    <investigator_full_name>Hirdaya H Nag, MS</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

